AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16002160 — intervention group
Group type: COMPARATOR
Intervention: No statin (Control)
Number of subjects: 47
Study 12796127 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 994
Study 11042867 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/Carbamazepine (BPN/CBZ)
Number of subjects: 27
Study 11042867 — intervention group
Group type: COMPARATOR
Intervention: Oxazepam/Carbamazepine (OXA/CBZ)
Number of subjects: 27
Study 8794707 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% fluorometholone
Number of subjects: 140
Study 8794707 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 140
Study 8794707 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (fluorometholone and vehicle)
Number of subjects: 140
Study 1378137 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (12.5-50 mg b.i.d. for 4-8 weeks)
Number of subjects: 65
Study 3000138 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg ACTH 4-9 analogue (Org 2766)
Number of subjects: 62
Study 3000138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 31335838 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU/day of vitamin D3
Number of subjects: 40
Study 31335838 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU/day of vitamin D3
Number of subjects: 40
Study 29203083 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal descriptors + percentage range (n=128)
Number of subjects: 393
Study 29203083 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage range (n=131)
Number of subjects: 393
Study 29203083 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute percentage (n=131)
Number of subjects: 393
Study 26387883 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS) plus usual care (UC)
Number of subjects: 29
Study 26387883 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) alone
Number of subjects: 29
Study 25338425 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 71
Study 25338425 — intervention group
Group type: EXPERIMENTAL
Intervention: GA
Number of subjects: 71
Study 23371871 — intervention group
Group type: EXPERIMENTAL
Intervention: Living room theatre activity offered by professional actors (E2)
Number of subjects: 147
Study 23371871 — intervention group
Group type: EXPERIMENTAL
Intervention: Living room theatre activity offered by trained caregivers (E1)
Number of subjects: 147
Study 23371871 — intervention group
Group type: COMPARATOR
Intervention: Reminiscence group activity (Control)
Number of subjects: 147
Study 19692216 — intervention group
Group type: EXPERIMENTAL
Intervention: VLC - very low carbohydrate diet (60% fat, 4% carbohydrate, n=30)
Number of subjects: 113
Study 19692216 — intervention group
Group type: EXPERIMENTAL
Intervention: VLF - very low fat diet (10% fat, n=30)
Number of subjects: 113
Study 19692216 — intervention group
Group type: EXPERIMENTAL
Intervention: HUF - high unsaturated fat diet (30% fat, n=30)
Number of subjects: 113
Study 19692216 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention, n=23)
Number of subjects: 113
Study 19692216 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet groups (VLC, VLF, HUF)
Number of subjects: 113
Study 17665550 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with known risk factors (4 risk factors)
Number of subjects: 2165
Study 17665550 — intervention group
Group type: COMPARATOR
Intervention: Individuals without known risk factors (0 risk factors)
Number of subjects: 2165
Study 18670743 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (lentinan, RFA, and TACE)
Number of subjects: 78
Study 18670743 — intervention group
Group type: COMPARATOR
Intervention: TACE only
Number of subjects: 78
Study 18670743 — intervention group
Group type: COMPARATOR
Intervention: RFA only
Number of subjects: 78
Study 18670743 — intervention group
Group type: COMPARATOR
Intervention: TACE/RFA
Number of subjects: 78
Study 15591594 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 24
Study 15591594 — intervention group
Group type: COMPARATOR
Intervention: Open diathermy haemorrhoidectomy
Number of subjects: 24
Study 15591594 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 24
Study 11312474 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 27
Study 11312474 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 27
Study 9161373 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 400mg orally three times a day for 48 hours
Number of subjects: 15
Study 9161373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8042734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital capacity breaths (4 or more)
Number of subjects: 0
Study 8042734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital capacity breaths (6)
Number of subjects: 0
Study 8042734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital capacity breaths (3)
Number of subjects: 0
Study 8042734 — intervention group
Group type: COMPARATOR
Intervention: Tidal breathing (3 min)
Number of subjects: 0
Study 3581690 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid baroreceptor stimulation during head-out water immersion
Number of subjects: 7
Study 3581690 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no immersion)
Number of subjects: 7
Study 31504615 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilapia skin
Number of subjects: 30
Study 31504615 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream 1%
Number of subjects: 30
Study 31848169 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab administered 4 to 8 weeks after the first rituximab infusion for 52 weeks
Number of subjects: 0
Study 31848169 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 4 to 8 weeks after the first rituximab infusion for 52 weeks
Number of subjects: 0
Study 31848169 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 0
Study 26040429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide 6 mcg/unit insulin
Number of subjects: 0
Study 26040429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide 9 mcg/unit insulin
Number of subjects: 0
Study 26040429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide 12 mcg/unit insulin
Number of subjects: 0
Study 26040429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24375222 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mL of 0.1285% ropivacaine
Number of subjects: 44
Study 22246644 — intervention group
Group type: EXPERIMENTAL
Intervention: Disc prosthesis
Number of subjects: 154
Study 22246644 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation
Number of subjects: 154
Study 22246644 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 154
Study 19383515 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Therapy (FET)
Number of subjects: 13
Study 19383515 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 13
Study 17341866 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied indigo naturalis ointment
Number of subjects: 14
Study 17341866 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment (control)
Number of subjects: 14
Study 16285544 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF 1.23% added to 35% phosphoric acid
Number of subjects: 64
Study 16285544 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF 2% added to 35% phosphoric acid
Number of subjects: 64
Study 16285544 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF 3% added to 35% phosphoric acid
Number of subjects: 64
Study 16285544 — intervention group
Group type: COMPARATOR
Intervention: NaF 0% (control) added to 35% phosphoric acid
Number of subjects: 64
Study 16285544 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (NaF 3%)
Number of subjects: 64
Study 12505248 — intervention group
Group type: EXPERIMENTAL
Intervention: Active hormone replacement therapy (conjugated estrogens for women who had had a hysterectomy or conjugated estrogens with medroxyprogesterone for women with intact uteri)
Number of subjects: 423
Study 12505248 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vitamins E and C
Number of subjects: 423
Study 12505248 — intervention group
Group type: COMPARATOR
Intervention: Placebo for hormone replacement therapy
Number of subjects: 423
Study 12505248 — intervention group
Group type: COMPARATOR
Intervention: Placebo for vitamins E and C
Number of subjects: 423
Study 9869222 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery alone
Number of subjects: 114
Study 9869222 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 114
Study 9869222 — intervention group
Group type: COMPARATOR
Intervention: Postoperative irradiation
Number of subjects: 114
Study 9869222 — intervention group
Group type: COMPARATOR
Intervention: Preoperative irradiation
Number of subjects: 114
Study 9869222 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (surgery and radiotherapy)
Number of subjects: 114
Study 7614811 — intervention group
Group type: COMPARATOR
Intervention: High sodium diet (200 mmol/day)
Number of subjects: 18
Study 7614811 — intervention group
Group type: COMPARATOR
Intervention: Low sodium diet (20 mmol/day)
Number of subjects: 18
Study 7614811 — intervention group
Group type: COMPARATOR
Intervention: Both diets
Number of subjects: 18
Study 2692667 — intervention group
Group type: EXPERIMENTAL
Intervention: diatrizoate (ionic)
Number of subjects: 20
Study 2692667 — intervention group
Group type: COMPARATOR
Intervention: iopromide (non-ionic)
Number of subjects: 20
Study 773493 — intervention group
Group type: EXPERIMENTAL
Intervention: Bran tablets
Number of subjects: 0
Study 773493 — intervention group
Group type: COMPARATOR
Intervention: High-roughage diet (HRD)
Number of subjects: 0
Study 773493 — intervention group
Group type: COMPARATOR
Intervention: Normacol plus an antispasmodic
Number of subjects: 0
Study 30760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical rhythmic skills
Number of subjects: 23
Study 30760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosody production test
Number of subjects: 23
Study 30760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm production abilities
Number of subjects: 23
Study 30843238 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care with no suction (intervention arm)
Number of subjects: 0
Study 30843238 — intervention group
Group type: COMPARATOR
Intervention: Usual postoperative care including suction (control arm)
Number of subjects: 0
Study 28916821 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg/day)
Number of subjects: 0
Study 28916821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26076690 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecolic reconstruction of gastro/duodenojejunostomy
Number of subjects: 534
Study 26076690 — intervention group
Group type: COMPARATOR
Intervention: Retrocolic reconstruction of gastro/duodenojejunostomy
Number of subjects: 534
Study 23400823 — intervention group
Group type: EXPERIMENTAL
Intervention: Velaglucerase alfa
Number of subjects: 35
Study 23400823 — intervention group
Group type: COMPARATOR
Intervention: Imiglucerase (60 U/kg every other week)
Number of subjects: 35
Study 23400823 — intervention group
Group type: COMPARATOR
Intervention: Imiglucerase
Number of subjects: 35
Study 21054224 — intervention group
Group type: EXPERIMENTAL
Intervention: MIST plus EMD
Number of subjects: 30
Study 21054224 — intervention group
Group type: COMPARATOR
Intervention: MIST alone
Number of subjects: 30
Study 19476072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS)
Number of subjects: 0
Study 19476072 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity simulation (LFS)
Number of subjects: 0
Study 17439510 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily for 1 week, followed by 3 weeks of esomeprazole 40 mg daily
Number of subjects: 1121
Study 15109761 — intervention group
Group type: EXPERIMENTAL
Intervention: Older women with limited dorsiflexion range of motion
Number of subjects: 15
Study 11288947 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboprophylactic agents (specific agents not mentioned)
Number of subjects: 0
Study 11288947 — intervention group
Group type: COMPARATOR
Intervention: New pharmacologic agent (specific agent not mentioned)
Number of subjects: 0
Study 11288947 — intervention group
Group type: EXPERIMENTAL
Intervention: Venography (as a method for end-point measurement)
Number of subjects: 0
Study 11288947 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive methods (as alternatives to venography)
Number of subjects: 0
Study 10211050 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogenized meal (HM)
Number of subjects: 8
Study 10211050 — intervention group
Group type: COMPARATOR
Intervention: Both meal types
Number of subjects: 8
Study 7933255 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart transplantation
Number of subjects: 68
Study 3358924 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya-bean protein (from soya-bean flour, soya-bean concentrate, or soya-bean isolate)
Number of subjects: 7
Study 3358924 — intervention group
Group type: COMPARATOR
Intervention: Meat protein (60 g)
Number of subjects: 7
Study 30543723 — intervention group
Group type: EXPERIMENTAL
Intervention: pink-veneered customized zirconia abutments (test group)
Number of subjects: 20
Study 30543723 — intervention group
Group type: COMPARATOR
Intervention: nonveneered customized zirconia abutments (control group)
Number of subjects: 20
Study 30543723 — intervention group
Group type: EXPERIMENTAL
Intervention: both groups
Number of subjects: 20
Study 28511917 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hypertonic saline (Ior)
Number of subjects: 32
Study 28511917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hypertonic saline (Iiv)
Number of subjects: 32
Study 28511917 — intervention group
Group type: COMPARATOR
Intervention: Oral hypertonic saline (IIor)
Number of subjects: 32
Study 28511917 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hypertonic saline (IIiv)
Number of subjects: 32
Study 28511917 — intervention group
Group type: COMPARATOR
Intervention: Group I vs Group II
Number of subjects: 32
Study 25908018 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate health literacy
Number of subjects: 575
Study 25908018 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal health literacy
Number of subjects: 575
Study 23650412 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with concurrent trastuzumab (arm C)
Number of subjects: 1802
Study 23650412 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with sequential trastuzumab (arm B)
Number of subjects: 1802
Study 23650412 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (arm A)
Number of subjects: 1802
Study 21767722 — intervention group
Group type: EXPERIMENTAL
Intervention: Qi-gong intervention
Number of subjects: 41
Study 19454781 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodex Stability System
Number of subjects: 21
Study 19454781 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrax System
Number of subjects: 21
Study 19454781 — intervention group
Group type: EXPERIMENTAL
Intervention: EquiTest system for EMG recording
Number of subjects: 21
Study 16461871 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reminders for immunization and WCC visits
Number of subjects: 3006
Study 16461871 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 3006
Study 14967774 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine hydrobromide
Number of subjects: 194
Study 11789776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 20
Study 11789776 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 20
Study 9670287 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed beam (neutron plus photon) irradiation
Number of subjects: 2
Study 9670287 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure neutron irradiation
Number of subjects: 2
Study 7800919 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage I (30 min after the beginning of anaesthesia)
Number of subjects: 15
Study 7800919 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage II (30 min after adding 30 cm of dead space)
Number of subjects: 15
Study 7800919 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage III (30 min after replacing the previous VD with VD of 60 cm)
Number of subjects: 15
Study 3353806 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya-based formula with a mixture of sucrose and glucose polymers
Number of subjects: 20
Study 3353806 — intervention group
Group type: EXPERIMENTAL
Intervention: Soya-based formula with all carbohydrate as glucose polymers
Number of subjects: 20
Study 3353806 — intervention group
Group type: COMPARATOR
Intervention: Cows' milk formula
Number of subjects: 20
Study 31456449 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrulline Malate (8g)
Number of subjects: 27
Study 31456449 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot Juice (400mg nitrate)
Number of subjects: 27
Study 31456449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 27
Study 31198990 — intervention group
Group type: EXPERIMENTAL
Intervention: donor motivational interview (n = 544)
Number of subjects: 1177
Study 31198990 — intervention group
Group type: COMPARATOR
Intervention: knowledge interview (n = 633)
Number of subjects: 1177
Study 31198990 — intervention group
Group type: EXPERIMENTAL
Intervention: donor motivational interview (n = 544) among women
Number of subjects: 1177
Study 28606215 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty fish (750 g/week)
Number of subjects: 68
Study 28606215 — intervention group
Group type: EXPERIMENTAL
Intervention: Lean fish (750 g/week)
Number of subjects: 68
Study 28606215 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal eating habits, no fish)
Number of subjects: 68
Study 26630617 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 20
Study 26630617 — intervention group
Group type: COMPARATOR
Intervention: 0.1% hyaluronate ophthalmic solution
Number of subjects: 20
Study 26630617 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study 24072808 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 114
Study 24072808 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 114
Study 21977856 — intervention group
Group type: EXPERIMENTAL
Intervention: Liandou Qingmai Recipe (treatment group, n = 45)
Number of subjects: 101
Study 21977856 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group, n = 56)
Number of subjects: 101
Study 20209464 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g GPLC
Number of subjects: 30
Study 20209464 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g GPLC
Number of subjects: 30
Study 20209464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 16549460 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon supplementation (1.5 g/d)
Number of subjects: 25
Study 16549460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 15327724 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive linguistic treatment
Number of subjects: 3
Study 15327724 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitative treatment
Number of subjects: 3
Study 12949287 — intervention group
Group type: EXPERIMENTAL
Intervention: Northstar Iontophoretic Drug Delivery System (IDDS) with lidocaine (100 mg of 10%) and epinephrine (1.05 mg of 1:10,000)
Number of subjects: 12
Study 10950829 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 7.5% dextrose in healthy adults
Number of subjects: 13
Study 10950829 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin deficiency in young adults with IDDM
Number of subjects: 13
Study 8981333 — intervention group
Group type: EXPERIMENTAL
Intervention: Oesclim 50
Number of subjects: 143
Study 8981333 — intervention group
Group type: COMPARATOR
Intervention: Estraderm TTS 50
Number of subjects: 143
Study 8981333 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 143
Study 1550697 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric coated 500 mg 5-ASA tablets administered after standard meals
Number of subjects: 12
Study 1550697 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric coated 500 mg 5-ASA tablets administered 1 h before meals
Number of subjects: 12
Study 3862607 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g oral N‐acetylcysteine/day for 60 days
Number of subjects: 12
Study 3862607 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12
Study 2887401 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdose intrauterine device releasing 2 micrograms of levonorgestrel per 24 hours
Number of subjects: 0
Study 2887401 — intervention group
Group type: COMPARATOR
Intervention: Copper IUDs (TCu 220C and Nova T)
Number of subjects: 0
Study 31919558 — intervention group
Group type: EXPERIMENTAL
Intervention: Molidustat alone (fasted or fed)
Number of subjects: 42
Study 31919558 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron(II)
Number of subjects: 42
Study 31919558 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium(II)
Number of subjects: 42
Study 31919558 — intervention group
Group type: EXPERIMENTAL
Intervention: Molidustat with iron(II) intake 4 hours before
Number of subjects: 42
Study 30307351 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental control behavioral intervention
Number of subjects: 222
Study 30307351 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 222
Study 28590957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (40 mg)
Number of subjects: 66
Study 28590957 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 66
Study 25585595 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation intervention (telephone calls from a bilingual patient navigator 7 days and 1 day before the appointment)
Number of subjects: 4425